Remove Blood Pressure Remove COVID-19 Remove Hypertension
article thumbnail

Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY

Open Heart

Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. Results The percentage of patients aged ≥45 years who had blood pressure screening recorded in the preceding 5 years decreased from 90% (March 2019) to 85% (March 2023).

article thumbnail

Rationale and Design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR): an observational phenotyping study

Open Heart

Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19 blood pressure endothelium interaction study’, which found that patients with normal blood pressure (BP) at the time of hospital admission with COVID-19 showed an 8.6

article thumbnail

Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran

The British Journal of Cardiology

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.

article thumbnail

RNA Therapeutics for the Cardiovascular System

Circulation

The effectiveness of mRNA-based vaccines in the recent COVID-19 pandemic has undoubtedly proven the benefits of an RNA-based approach. This is most evident in hypertension where several small interfering RNA–based drugs have proven to be effective in managing high blood pressure in several clinical trials.

COVID-19 102
article thumbnail

Personalized Antihypertensive Treatment Optimization With Smartphone?Enabled Remote Precision Dosing of Amlodipine During the COVID?19 Pandemic (PERSONAL?CovidBP Trial)

Journal of the American Heart Association

Participants aged ≥18 years with uncontrolled hypertension (5–7 day baseline mean ≥135 mm Hg systolic BP or ≥85 mm Hg diastolic BP) received personalized amlodipine dose titration using novel (1, 2, 3, 4, 6, 7, 8, 9 mg) and standard (5 and 10 mg) doses daily over 14 weeks.

article thumbnail

Physiology Friday #215: Sitting Less Improves Blood Pressure

Physiologically Speaking

Prolonged sitting also leads to a bending of major arteries in our legs, leading to a blood flow pattern known as turbulent flow, blood pooling, impaired circulation, and endothelial dysfunction. They also had measures of body weight and circumferences and blood pressure assessed at these time points. kilograms (7.7

article thumbnail

Detection and Control of Pregnancy Hypertension Using Self-Monitoring of Blood Pressure With Automated Telemonitoring: Cost Analyses of the BUMP Randomized Trials

Hypertension Journal

Hypertension, Ahead of Print. BACKGROUND:Pregnancy hypertension continues to cause maternal and perinatal morbidity. Within BUMP 2, chronic and gestational hypertension cohorts were analyzed separately. This article reports the trials’ integrated cost analyses.METHODS:Two cost analyses.